Holen Sie sich die Stockscreener-App
1.43
3.38%
-0.05
Schlusskurs vom Vortag:
$1.48
Offen:
$1.51
24-Stunden-Volumen:
42,275
Relative Volume:
0.08
Marktkapitalisierung:
$49.81M
Einnahmen:
-
Nettoeinkommen (Verlust:
-
KGV:
-16.21
EPS:
-0.0882
Netto-Cashflow:
-
1W Leistung:
-10.63%
1M Leistung:
-11.73%
6M Leistung:
+113.75%
1J Leistung:
+0.00%
1-Tages-Spanne:
$1.41
$1.51
1-Wochen-Bereich:
$1.41
$1.66
52-Wochen-Spanne:
$0.51
$19.51
Jupiter Neurosciences Inc Stock (JUNS) Company Profile
Firmenname
Jupiter Neurosciences Inc
Sektor
Branche
Telefon
(561) 406-6154
Adresse
1001 NORTH US HWY 1, JUPITER
Vergleichen Sie JUNS mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
JUNS
Jupiter Neurosciences Inc
|
1.43 | 50.16M | 0 | 0 | 0 | -0.0882 |
|
VRTX
Vertex Pharmaceuticals Inc
|
388.97 | 99.72B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
588.79 | 60.67B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
452.29 | 58.15B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
705.74 | 41.45B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
299.97 | 36.69B | 3.81B | -644.79M | -669.77M | -6.24 |
Jupiter Neurosciences Inc Aktie (JUNS) Neueste Nachrichten
Jupiter Neurosciences Inc. stock chart pattern explainedMarket Sentiment Review & Entry Point Confirmation Signals - Newser
Is Jupiter Neurosciences Inc. stock bottoming outJuly 2025 Pullbacks & Safe Capital Growth Stock Tips - Newser
Combining price and volume data for Jupiter Neurosciences Inc.July 2025 EndofMonth & Reliable Volume Spike Alerts - Newser
Jupiter Neurosciences Launches Nugevia™ Website and Opens - GlobeNewswire
Jupiter Neurosciences Launches Nugevia Website and Pre-Orders for Longevity Supplements. - AInvest
$8 Trillion Market Opportunity: Jupiter Neurosciences Launches Clinical-Grade Longevity Supplements - Stock Titan
Predicting Jupiter Neurosciences Inc. trend using moving averagesWeekly Stock Recap & Low Drawdown Investment Ideas - Newser
Top chart patterns to watch in Jupiter Neurosciences Inc.Trade Volume Report & Real-Time Stock Price Movement Reports - Newser
Has Jupiter Neurosciences Inc. found a price floorBull Run & Weekly Top Gainers Trade List - Newser
Multi asset correlation models including Jupiter Neurosciences Inc.2025 Market Outlook & Real-Time Market Trend Scan - Newser
How Jupiter Neurosciences Inc. stock performs during market volatilityQuarterly Profit Report & Reliable Intraday Trade Alerts - Newser
Bull Bear: Is Jupiter Neurosciences Inc.’s growth already priced inWeekly Trade Report & Daily Price Action Insights - sundaytimes.kr
When is the best time to buy Jupiter Neurosciences Inc. stockJuly 2025 Update & AI Driven Price Predictions - Newser
A | Can Jupiter Neurosciences, Inc. lead its sector in growthIPO Watch & Free Low Drawdown Momentum Trade Ideas - theviewers.co.kr
Jupiter Neurosciences Inc. Recovery Likely Here’s What Data ShowsJuly 2025 Spike Watch & Community Trade Idea Sharing Platform - kangso.co.kr
Jupiter Neurosciences Launches Consumer Longevity Line Nugevia Using Patented JOTROL Technology - citybuzz -
Jupiter Neurosciences shares rise 2.03% after-hours as CEO and President discuss longevity and brain health initiatives. - AInvest
Can Jupiter Neurosciences Inc. deliver consistent dividends2025 Year in Review & Smart Investment Allocation Insights - theviewers.co.kr
Jupiter Neurosciences CEO And President Talk About The Power of JOTROL And The Launch of Its Longevity Consumer Line With Benzinga - NewMediaWire
Jupiter Neurosciences (JUNS) Surges 17% on High-Profile Partnership with NBA Legend Chris Webber – Is This the Catalyst for a Longevity Market Breakout? - AInvest
Jupiter Neurosciences Names Chris Webber as Nugevia Brand Ambassador - AInvest
Analyzing recovery setups for Jupiter Neurosciences Inc. investorsJuly 2025 PreEarnings & Growth Focused Entry Point Reports - Newser
Real time scanner hits for Jupiter Neurosciences Inc. explainedJuly 2025 Momentum & Risk Controlled Swing Trade Alerts - Newser
Will Jupiter Neurosciences Inc. benefit from macro trendsRate Hike & Low Risk Investment Opportunities - Newser
Intrinsic Value of Jupiter Neurosciences Inc. Stock: Is It Undervalued or OvervaluedEarnings Summary Report & Breakout Confirmation Alerts - Newser
Longevity In A Capsule: Jupiter Neurosciences Launches First Three Supplements Under Nugevia™ Brand - NewMediaWire
Jupiter Neurosciences launches Nugevia MND to support cognitive function and brain health - Nutritional Outlook
Jupiter Neurosciences Inc. recovery potential after sell offJuly 2025 Movers & Expert Approved Momentum Ideas - Newser
Jupiter Neurosciences names NBA Legend Chris Webber as second Nugevia brand ambassador - Mass Market Retailers
Jupiter Neurosciences Launches Nugevia™ Longevity Supplement Line to Accelerate Revenue While Developing CNS Treatments - citybuzz -
Longevity In A Capsule: Jupiter Neurosciences Launches First Three Supplements Under Nugevia(TM) Brand - FinancialContent
Jupiter Neurosciences Names NBA Legend Chris Webber as Second Nugevia™ Brand Ambassador - The Manila Times
Jupiter Neurosciences, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2025 - MarketScreener
Chart based analysis of Jupiter Neurosciences Inc. trendsPortfolio Value Report & Expert Verified Stock Movement Alerts - Newser
Jupiter Neurosciences Inc. stock prediction for this weekQuarterly Portfolio Report & Daily Volume Surge Signals - Newser
5-Time NBA All-Star Chris Webber Partners with Jupiter Neurosciences for $8T Longevity Market Push - Stock Titan
Is Jupiter Neurosciences Inc. Starting a New UptrendQuarterly Portfolio Summary & AI Driven Stock Price Forecasts - 선데이타임즈
Will Jupiter Neurosciences Inc. Bounce From 52 Week Low2025 Price Momentum & Fast Moving Stock Watchlists - newsimpact.co.kr
Recovery Signals Appearing in Jupiter Neurosciences Inc. ChartsEntry Point & Capital Efficiency Focused Ideas - sundaytimes.kr
Visual trend scoring systems applied to Jupiter Neurosciences Inc.2025 Technical Overview & Stock Timing and Entry Methods - Newser
Why Jupiter Neurosciences Inc. stock attracts strong analyst attentionTrade Performance Summary & AI Enhanced Market Trend Forecasts - 더경남뉴스
Is Jupiter Neurosciences Inc. stock poised for growthJuly 2025 Update & Consistent Return Strategy Ideas - Newser
Is Jupiter Neurosciences Inc. a Top Dividend Stock to Watch in 2025Trend Reversal & Daily Stock Momentum Reports - Newser
Is a relief rally coming for Jupiter Neurosciences Inc. holdersJuly 2025 Spike Watch & Growth Focused Investment Plans - Newser
Applying chart zones and confluence areas to NLY.PRF2025 Breakouts & Breakdowns & Verified Momentum Stock Alerts - Newser
Finanzdaten der Jupiter Neurosciences Inc-Aktie (JUNS)
Umsatz
Nettogewinn
Free Cashflow
ENV
Jupiter Neurosciences Inc-Aktie (JUNS) Insiderhandel
| Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
|---|---|---|---|---|---|---|---|
| Silva Alison D. | Pres + Chief Business Officer |
Jul 01 '25 |
Buy |
1.03 |
750 |
772 |
112,777 |
| ROSEN CHRISTER | CEO and Chairman |
Jul 01 '25 |
Buy |
1.02 |
3,600 |
3,667 |
11,078,892 |
| Silva Alison D. | Pres + Chief Business Officer |
Jun 02 '25 |
Option Exercise |
0.00 |
110,227 |
0 |
110,227 |
| Silva Alison D. | Pres + Chief Business Officer |
Jun 30 '25 |
Buy |
1.03 |
950 |
978 |
112,027 |
| Silva Alison D. | Pres + Chief Business Officer |
Jun 27 '25 |
Buy |
1.03 |
850 |
877 |
111,077 |
| ROSEN CHRISTER | CEO and Chairman |
Jun 02 '25 |
Option Exercise |
0.00 |
973,466 |
0 |
11,067,476 |
| ROSEN CHRISTER | CEO and Chairman |
Jun 30 '25 |
Buy |
1.02 |
7,650 |
7,810 |
11,075,292 |
| ROSEN CHRISTER | CEO and Chairman |
Jun 27 '25 |
Buy |
1.06 |
166 |
176 |
11,067,642 |
0.57%
9.25%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):